177 related articles for article (PubMed ID: 23709654)
1. Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer.
Klubo-Gwiezdzinska J; Costello J; Patel A; Bauer A; Jensen K; Mete M; Burman KD; Wartofsky L; Vasko V
J Clin Endocrinol Metab; 2013 Aug; 98(8):3269-79. PubMed ID: 23709654
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
[TBL] [Abstract][Full Text] [Related]
3. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
[TBL] [Abstract][Full Text] [Related]
4. The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma.
Psutka SP; Boorjian SA; Lohse CM; Stewart SB; Tollefson MK; Cheville JC; Leibovich BC; Thompson RH
Urol Oncol; 2015 Feb; 33(2):67.e15-23. PubMed ID: 25153774
[TBL] [Abstract][Full Text] [Related]
5. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
6. Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention.
Kao J; Tobis J; McClelland RL; Heaton MR; Davis BR; Holmes DR; Currier JW;
Am J Cardiol; 2004 Jun; 93(11):1347-50, A5. PubMed ID: 15165912
[TBL] [Abstract][Full Text] [Related]
7. [Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes].
Bershteĭn LM; Turkevich EA; Boiarkina MP
Vopr Onkol; 2012; 58(2):194-8. PubMed ID: 22774523
[TBL] [Abstract][Full Text] [Related]
8. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2018 Feb; 59(2):383-394. PubMed ID: 29285650
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.
Chen G; Xu S; Renko K; Derwahl M
J Clin Endocrinol Metab; 2012 Apr; 97(4):E510-20. PubMed ID: 22278418
[TBL] [Abstract][Full Text] [Related]
11. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
12. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.
Jiralerspong S; Palla SL; Giordano SH; Meric-Bernstam F; Liedtke C; Barnett CM; Hsu L; Hung MC; Hortobagyi GN; Gonzalez-Angulo AM
J Clin Oncol; 2009 Jul; 27(20):3297-302. PubMed ID: 19487376
[TBL] [Abstract][Full Text] [Related]
13. Metformin Has Positive Therapeutic Effects in Colon Cancer and Lung Cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
[TBL] [Abstract][Full Text] [Related]
15. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
16. Are levothyroxine requirements lower in thyroidectomized diabetic patients on metformin treatment?
Casteràs A; Zafon C; Ciudin A; Mesa J
Thyroid; 2013 Dec; 23(12):1510-3. PubMed ID: 23758637
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin on the incidence of head and neck cancer in diabetics.
Yen YC; Lin C; Lin SW; Lin YS; Weng SF
Head Neck; 2015 Sep; 37(9):1268-73. PubMed ID: 24801563
[TBL] [Abstract][Full Text] [Related]
18. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma.
Sandulache VC; Hamblin JS; Skinner HD; Kubik MW; Myers JN; Zevallos JP
Head Neck; 2014 Jul; 36(7):1039-43. PubMed ID: 23784886
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
20. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
